Organisation paid for research Program year 2025 Source: CMS Open Payments

Bluegrass Allergy Care

Neither a doctor nor a teaching hospital

Research payments

$66,226

9 payments

Through program year 2025, Bluegrass Allergy Care is reported as receiving $66,226 in research payments, across 9 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $43,579 6
2024 Research $21,437 2
2022 Research $1,210 1

Breakdown

Who paid Research payments · program years 2022–2025
  1. GlaxoSmithKline, LLC. $43,579 6 payments
  2. Amgen Inc. $22,647 3 payments
Studies the money was for Research payments · program years 2022–2025
  1. A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Para $38,551 2 payments
  2. ORBIT P3 AD Adolescent Open Label Safety $21,437 2 payments
  3. A 52-Week, Randomised, Double-Blind, Double-Dummy, Parallel Group, Mul $3,390 2 payments
  4. A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the $1,638 2 payments
  5. Ph2b_chronic urticaria $1,210 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record